Nevertheless, their interaction is likely to be altered in the present context since, during weight loss, people with overweight or obesity usually decrease in their FGF21 levels while simultaneously increasing in adiponectin levels (Soni et al., 2011; Gómez-Ambrosi et al., 2017). The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.